Abbonarsi

Short, Medium and Long-Term Cause-Specific Mortality Following First-Ever Heart Failure Hospitalisation in New Zealand - 18/09/24

Doi : 10.1016/j.hlc.2024.05.009 
Daniel Z.L. Chan, MBChB a, , Rob N. Doughty, MBBS, MD b, c, Katrina K. Poppe, BAppSci, MSc, PhD b, Matire Harwood, MBChB, PhD d, Mildred Ai Wei Lee, BTech, MSc e, Andrew J. Kerr, MBChB, MD b, d, f
a Department of Cardiology, Te Whatu Ora Health New Zealand Te Tai Tokerau. Whangarei, New Zealand 
b Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand 
c Greenlane Cardiovascular Service, Te Whatu Ora Health New Zealand Te Toka Tumai, Auckland Hospital, Auckland, New Zealand 
d Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand 
e Department of Cardiology, Te Whatu Ora Health New Zealand Counties Manukau, Auckland, New Zealand 
f Section of Epidemiology and Biostatistics, School of Population Health, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand 

Corresponding author at: Department of Cardiology, Private Bag 9742, Whangarei 0148, New ZealandDepartment of CardiologyPrivate Bag 9742Whangarei0148New Zealand

Abstract

Background

Heart failure (HF) is associated with high mortality, but there are limited reports on the underlying cause of death. This study reports short-, medium- and long-term cause-specific mortality following first-ever HF hospitalisation in New Zealand.

Method

First-ever HF hospitalisations were identified from hospital discharge coding between 2010 and 2013. Mortality outcomes were obtained via anonymised linkage to national datasets. Short (0–30 days), medium (31–364 days), and long-term (1–5 years) mortality rates were identified. Cause of death was identified from death certification coding and classified as cardiovascular and non-cardiovascular. Cox regression analysis was performed to adjust for confounding variables.

Results

A cohort of 34,264 individuals with first-ever HF hospitalisation were identified. Mean age was 75.8±13 years and 50.5% were male. A total of 21,637 (63.1%) died within 5 years of hospitalisation; 4,122 (12.0%) within the first 30 days, 6,358 (18.6%) between 31–364 days, and 11,157 (32.6%) between 1 and 5 years. Older age, male gender, Māori ethnicity, higher socioeconomic deprivation and increased comorbidity were independent factors associated with higher all-cause mortality. Cardiovascular causes accounted for 51% of total deaths. Cardiovascular mortality was 6.0%, 9.5%, and 16.7% at 30 days, 31–364 days, and 1–5 years, respectively. The most common causes of non-cardiovascular mortality were neoplasms, chronic respiratory diseases and infections, accounting for 14.6%, 11.0%, and 5.5% of total deaths respectively. Comorbidity was associated with higher non-cardiovascular mortality (hazard ratio [HR] 3.35; 95% confidence interval [CI] 3.16–3.55) but not cardiovascular mortality (HR 0.79; 95% CI 0.72–0.86).

Conclusions

In New Zealand, mortality following first-ever HF hospitalisation is high. Non-cardiovascular death is common and there are ethnic inequities.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Heart failure, Mortality, Survival, Epidemiology, Ethnicity


Mappa


© 2024  Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 33 - N° 10

P. 1475-1483 - ottobre 2024 Ritorno al numero
Articolo precedente Articolo precedente
  • Accuracy of a Single-Lead ECG Device for Diagnosis of Cardiac Arrhythmias Compared Against Cardiac Electrophysiology Study
  • Samual Turnbull, Kartheek Garikapati, Richard G. Bennett, Timothy G. Campbell, Yasuhito Kotake, Kasun De Silva, Rajiv Mahajan, Mary S. Wong, Samia Kazi, Simone Marschner, Karen Byth, Stuart P. Thomas, Clara K. Chow, Saurabh Kumar
| Articolo seguente Articolo seguente
  • Infective Endocarditis in Patients With Bicuspid Aortic Valves: Unique Clinical and Microbiologic Features
  • Juan A. Quintero-Martinez, Joya-Rita Hindy, Hector I. Michelena, Daniel C. DeSimone, Larry M. Baddour

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.